Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 17alpha-estradiol via stereoselective inversion. Reliable supplier offering high-purity pharmaceutical intermediates with scalable, cost-effective processes.
Novel zinc-catalyzed cyclization route eliminates palladium, reducing costs and impurities for high-purity Tezacaftor intermediate manufacturing.
Advanced synthesis of rigid adamantane ligands via patent CN102153510A. Offers cost reduction in fine chemical manufacturing and scalable production for coordination chemistry applications.
Patent CN102040572A details a green synthesis of benzofuranone using cationic resin, offering high purity and reduced corrosion for azoxystrobin manufacturing.
Patent CN102548959B reveals novel TBIC solvent method enhancing yield and reducing distillation costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN100554269C reveals a Lewis acid-catalyzed route for triazole pyrimidines, offering high purity and reduced corrosion for agrochemical intermediate manufacturing.
Novel synthesis of lappaconitine acetal derivatives offers mild conditions and high safety for scalable antitumor pharmaceutical intermediates manufacturing supply chains.
Patent CN106632365B reveals a novel one-pot synthesis for high-purity lappaconitine-isatin hybrids, offering significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101397277A reveals a high-purity route for aminomethyl biphenyl tetrazole salts, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN116283880A reveals a novel Bi(OTf)3-catalyzed route for indeno[2,1,c]chromenes, offering significant cost reduction and simplified supply chain for pharmaceutical intermediates.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Patent CN111560005A details green synthesis of 2-thiopheneacetyl chloride offering high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN1266145C reveals a novel ester-mediated synthesis of Δ9-THC, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing without heavy metal residues.
Patent CN111187163A reveals a solvent-free Lewis acid catalyzed route for prohexadione calcium intermediates, offering high purity and scalable manufacturing for global agrochemical supply chains.
Patent CN102115354A details a green FeCl3 catalyzed allylation method. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN117510342A reveals improved 2,4-MDA selectivity via multi-step acid catalysis. Enhances supply chain stability and reduces manufacturing costs for global buyers.
Novel dual-acid catalyzed route for high-purity alpha-terpineol. Reduces cost and improves selectivity compared to traditional turpentine hydration methods.
Patent CN102351696B details green catalyst route for acetyl citrate. Reduces waste and cost for plasticizer manufacturing supply chains significantly.
Patent CN105541773A details a green synthesis route for 3,4-dihydro-4-arylcoumarins using recyclable catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.